Extramammary Paget's disease epidemiology and demographics: Difference between revisions
Simrat Sarai (talk | contribs) |
Simrat Sarai (talk | contribs) |
||
| Line 8: | Line 8: | ||
*Extramammary Paget disease can also occur in association with invasive carcinomas of the genitourinary or gastrointestinal tract. The frequency of that association varies from 9% to 32%. Invasive genitourinary tract cancers or gastrointestinal sites can be associated, synchronously or metachronously, with penoscrotal extramammary Paget's disease, but the frequency of this association has not been reported. | *Extramammary Paget disease can also occur in association with invasive carcinomas of the genitourinary or gastrointestinal tract. The frequency of that association varies from 9% to 32%. Invasive genitourinary tract cancers or gastrointestinal sites can be associated, synchronously or metachronously, with penoscrotal extramammary Paget's disease, but the frequency of this association has not been reported. | ||
*The majority of extramammary Paget's disease findings (approximately 76%) are accounted by vulvar EMPD, although vulvar EMPD remains a rare neoplastic finding, representing less than 1% of the vulvar neoplasms. Between 17% and 30% of the patients with EMPD may have an underlying adenocarcinoma. | *The majority of extramammary Paget's disease findings (approximately 76%) are accounted by vulvar EMPD, although vulvar EMPD remains a rare neoplastic finding, representing less than 1% of the vulvar neoplasms. Between 17% and 30% of the patients with EMPD may have an underlying adenocarcinoma. | ||
*A higher rate of underlying adenocarcinoma was | *A higher rate of underlying adenocarcinoma was found in patients with perianal involvement and palpable masses in the vulvar region. In approximately 10-20% of cases EMPD is associated to coexisting malignancies at other sites, as the breast, the rectum,the skin basal cells, the genitourinary tract and the cervix. | ||
found in patients with perianal involvement and palpable masses in the vulvar region. In approximately 10-20% of cases EMPD is associated to coexisting malignancies at other sites, as the breast, the rectum,the skin basal cells, the genitourinary tract and the cervix. A relationship between the site of EMPD and the probability to find an adenocarcinoma of cutaneous adnexal structures or an internal malignancy, has been suggested by a Spanish study. The study reports that vulvar EMPD was associated with adnexal adenocarcinoma in 4% of cases and with a distant malignancy in 20%, while perianal EMPD was associated with adnexal adenocarcinoma in 7% of cases and with an | *A relationship between the site of EMPD and the probability to find an adenocarcinoma of cutaneous adnexal structures or an internal malignancy, has been suggested by a Spanish study. The study reports that vulvar EMPD was associated with adnexal adenocarcinoma in 4% of cases and with a distant malignancy in 20%, while perianal EMPD was associated with adnexal adenocarcinoma in 7% of cases and with an | ||
internal malignancy in 14%.<ref name="MorettoNair2013">{{cite journal|last1=Moretto|first1=P.|last2=Nair|first2=V.J.|last3=El Hallani|first3=S.|last4=Malone|first4=S.|last5=Belanger|first5=E.|last6=Morash|first6=C.|last7=Canil|first7=C.M.|title=Management of penoscrotal extramammary Paget disease: case series and review of the literature|journal=Current Oncology|volume=20|issue=4|year=2013|pages=311|issn=1718-7729|doi=10.3747/co.20.1353}}</ref> | internal malignancy in 14%.<ref name="MorettoNair2013">{{cite journal|last1=Moretto|first1=P.|last2=Nair|first2=V.J.|last3=El Hallani|first3=S.|last4=Malone|first4=S.|last5=Belanger|first5=E.|last6=Morash|first6=C.|last7=Canil|first7=C.M.|title=Management of penoscrotal extramammary Paget disease: case series and review of the literature|journal=Current Oncology|volume=20|issue=4|year=2013|pages=311|issn=1718-7729|doi=10.3747/co.20.1353}}</ref> | ||
Revision as of 20:35, 2 February 2016
|
Extramammary Paget's disease Microchapters |
|
Differentiating Extramammary Paget's disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extramammary Paget's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Extramammary Paget's disease epidemiology and demographics |
|
FDA on Extramammary Paget's disease epidemiology and demographics |
|
CDC on Extramammary Paget's disease epidemiology and demographics |
|
Extramammary Paget's disease epidemiology and demographics in the news |
|
Blogs on Extramammary Paget's disease epidemiology and demographics |
|
Directions to Hospitals Treating Extramammary Paget's disease |
|
Risk calculators and risk factors for Extramammary Paget's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Extramammary Paget's disease is rare and the precise incidence is unknown. Extramammary Paget's disease commonly affects individuals 50-60 years of age. Females are more commonly affected with the disease than males. The female to male ratio is approximately 4.5-3 to 1. It usually affects individuals of the Caucasian race, but it may occur in other races.[1]
Epidemiology and Demographics
- Vulval extramammary Paget's disease represents 1% to 5% of all vulval malignancies, with a peak age incidence of 65 years.[2][3]
- Extramammary Paget disease can also occur in association with invasive carcinomas of the genitourinary or gastrointestinal tract. The frequency of that association varies from 9% to 32%. Invasive genitourinary tract cancers or gastrointestinal sites can be associated, synchronously or metachronously, with penoscrotal extramammary Paget's disease, but the frequency of this association has not been reported.
- The majority of extramammary Paget's disease findings (approximately 76%) are accounted by vulvar EMPD, although vulvar EMPD remains a rare neoplastic finding, representing less than 1% of the vulvar neoplasms. Between 17% and 30% of the patients with EMPD may have an underlying adenocarcinoma.
- A higher rate of underlying adenocarcinoma was found in patients with perianal involvement and palpable masses in the vulvar region. In approximately 10-20% of cases EMPD is associated to coexisting malignancies at other sites, as the breast, the rectum,the skin basal cells, the genitourinary tract and the cervix.
- A relationship between the site of EMPD and the probability to find an adenocarcinoma of cutaneous adnexal structures or an internal malignancy, has been suggested by a Spanish study. The study reports that vulvar EMPD was associated with adnexal adenocarcinoma in 4% of cases and with a distant malignancy in 20%, while perianal EMPD was associated with adnexal adenocarcinoma in 7% of cases and with an
internal malignancy in 14%.[4]
Incidence
Extramammary Paget's disease is rare and the precise incidence is unknown.
Prevalence
The prevalence of invasive extramammary Paget's disease is estimated to occur in 5-25% of patients.
Age
Extramammary Paget's disease commonly affects individuals 50-60 years of age. The median age of incidence of vulval disease was 65 years. The median age for a diagnosis of scrotal disease was 70.4 years; for penile disease, it was 73.6 years. After exclusion of vulvar disease, extramammary Paget's disease was most commonly seen in the scrotum and penis, followed by the anorectal area.[4]
Gender
Females are more commonly affected with extramammary Paget's disease than males. The female to male ratio is approximately 4.5-3 to 1.[1]
Race
Extramammary Paget's disease usually affects individuals of the Caucasian race, but it may occur in other races.[5]
References
- ↑ 1.0 1.1 Chanda JJ (1985). "Extramammary Paget's disease: prognosis and relationship to internal malignancy". J Am Acad Dermatol. 13 (6): 1009–14. PMID 3001158.
- ↑ Curtin JP, Rubin SC, Jones WB, Hoskins WJ, Lewis JL (1990). "Paget's disease of the vulva". Gynecol Oncol. 39 (3): 374–7. PMID 2175288.
- ↑ Lloyd J, Flanagan AM (2000). "Mammary and extramammary Paget's disease". J Clin Pathol. 53 (10): 742–9. PMC 1731095. PMID 11064666.
- ↑ 4.0 4.1 Moretto, P.; Nair, V.J.; El Hallani, S.; Malone, S.; Belanger, E.; Morash, C.; Canil, C.M. (2013). "Management of penoscrotal extramammary Paget disease: case series and review of the literature". Current Oncology. 20 (4): 311. doi:10.3747/co.20.1353. ISSN 1718-7729.
- ↑ Zollo, J.D.; Zeitouni, N.C. (2000). "The Roswell Park Cancer Institute experience with extramammary Paget's disease". British Journal of Dermatology. 142 (1): 59–65. doi:10.1046/j.1365-2133.2000.03242.x. ISSN 0007-0963.